Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vimab Group ABOSTO:VIMAB +6.86%55 Debt-to-Equity is 8.02 as of Mar. 2026, which is 4356% above its 10-year median of 0.18. GuruFocus rates OSTO:VIMAB with a GF Score™ of 55/100 and a GF Value™ of kr5.87 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 955 Business Services companies, Vimab Group AB ranks worse than 98.95% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Vimab Group AB's Debt-to-Equity or its related term are showing as below:
OSTO:VIMAB'
s Debt-to-Equity Range Over the Past 10 Years
Min: -29.4 Med: 0.18 Max: 17.73
Current: 8.02
During the past 13 years, the highest Debt-to-Equity Ratio of Vimab Group AB was 17.73. The lowest was -29.40. And the median was 0.18.
OSTO:VIMAB's Debt-to-Equity is ranked worse than 98.95% of 955
companies
in the Business Services industry
Industry Median: 0.33
vs OSTO:VIMAB: 8.02
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Vimab Group AB Debt-to-Equity Related Terms
Vimab Group AB Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Vimab Group AB's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:VIMAB vs VRSK, EFX, BAH: Debt-to-Equity Comparison
For the Consulting Services subindustry, Vimab Group AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimab Group AB Debt-to-Equity vs Business Services Industry
For the Business Services industry and Industrials sector, Vimab Group AB's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Vimab Group AB's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimab Group AB (OSTO:VIMAB) has a Debt-to-Equity of 8.02 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Vimab Group AB and its competitors. This is 4356% above median its historical median of 0.18. According to the industry distribution chart, Vimab Group AB ranks #945 out of 955 companies in the Business Services industry, placing it in the top 99%.
Is Vimab Group AB's Debt-to-Equity too high?
Vimab Group AB's current Debt-to-Equity of 8.02 is 4356% above median its 10-year median of 0.18. The Business Services industry median Debt-to-Equity is 0.33. Vimab Group AB's value of 8.02 is 2330.3% above this industry median. Based on the distribution chart, Vimab Group AB ranks #945 out of 955 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, Vimab Group AB has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's Debt-to-Equity compare to VRSK and EFX?
According to the Business Services industry distribution chart, Vimab Group AB ranks #945 out of 955 companies for Debt-to-Equity. This places Vimab Group AB in the lower half of its industry. The industry median Debt-to-Equity is 0.33. Vimab Group AB's value of 8.02 is 2330.3% above this benchmark. While the company's 10-year median is 0.18 vs. the industry median of 0.33, Vimab Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Business Services company?
The median Debt-to-Equity among Business Services companies is 0.33, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimab Group AB's current Debt-to-Equity of 8.02 is 2330.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Vimab Group AB and its competitors. For the Business Services industry, the median Debt-to-Equity is 0.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimab Group AB's current Debt-to-Equity is 8.02, which is 4356% above median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Modestly Undervalued. The stock's GF Value™ is kr5.87, compared to a current price of kr5.14 — trading 12.4% below its estimated fair value. The current Debt-to-Equity is 8.02, which is 4356% above median its 10-year median of 0.18 and 2330.3% above the Business Services industry median of 0.33. Vimab Group AB's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current Debt-to-Equity is 8.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued.
The current stock price of kr5.14 is trading 12.4% below its estimated GF Value™ of kr5.87.
GuruFocus considers Vimab Group AB to be Modestly Undervalued.
Key valuation signals for OSTO:VIMAB:
Debt-to-Equity: 8.02 (4356% above median its 10-year median of 0.18)
GF Value™: kr5.87 vs. price of kr5.14 (12.4% below fair value)
Industry Position: 2330.3% above the Business Services median (#945 of 955)
No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
55GF Score
Get the complete analysis for OSTO:VIMAB
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:VIMAB has been successfully added to your 
